EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Performance of the EndPAC risk score for pancreatic cancer in new onset diabetes patients with missing data – a database study in the British population

C Mellenthin, C R Meier, S S Jick, L H Bühler, M Adamina, C Schneider

Pancreatology · 2025-12 · 25 (8) · 1434-1441

DOI: 10.1016/j.pan.2025.09.017 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pancreatology, 2025-12. Verfasst von C Mellenthin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Hospital Fribourg, Switzerland; Arztpraxis am Bager, Schmitten, Switzerland; Basel Pharmacoepidemiology Unit, Division of Clin…. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Diabetes Mellitus, Carcinoma, Pancreatic Ductal. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Stiftung Krebsforschung Schweiz.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsDiabetes MellitusCarcinoma, Pancreatic DuctalHumansUnited KingdomFemaleMaleMiddle AgedRetrospective StudiesAgedDatabases, FactualRisk FactorsAdultRisk AssessmentAged, 80 and over

Stichwörter der Autor:innen

Cancer screeningMissing dataNew onset diabetesPancreatic cancerPrimary care

Autor:innen und Institutionen

  • Department of Surgery, Hospital Fribourg, Switzerland; Arztpraxis am Bager, Schmitten, Switzerland; Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacy and Epidemiology, Department of Pharmaceutical Sciences,…
  • Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacy and Epidemiology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland; Hospital Pharmacy, University Hospital Basel, Basel, Switz…
  • Boston Collaborative Drug Surveillance Program, Lexington, MA, United States; Boston University School of Public Health, Boston, MA, United States.
  • Department of Surgery, Hospital Fribourg, Switzerland; Department of of Medical and Surgical Specialties, Faculty of Science and Medicine, University of Fribourg, Switzerland.
  • Department of of Medical and Surgical Specialties, Faculty of Science and Medicine, University of Fribourg, Switzerland; Faculty of Medicine, University of Basel, Basel, Switzerland.

Förderung

  • Stiftung Krebsforschung Schweiz

Zitieren

APA

Mellenthin, C., Meier, C. R., Jick, S. S., Bühler, L. H., Adamina, M., & Schneider, C. (2025). Performance of the EndPAC risk score for pancreatic cancer in new onset diabetes patients with missing data – a database study in the British population. Pancreatology, 25(8), 1434-1441. https://doi.org/10.1016/j.pan.2025.09.017

Vancouver

Mellenthin C, Meier CR, Jick SS, Bühler LH, Adamina M, Schneider C. Performance of the EndPAC risk score for pancreatic cancer in new onset diabetes patients with missing data – a database study in the British population. Pancreatology. 2025;25(8):1434-1441. doi:10.1016/j.pan.2025.09.017

BibTeX
@article{Mellenthin2025,
  author = {Mellenthin, C and Meier, C R and Jick, S S and Bühler, L H and Adamina, M and Schneider, C},
  title = {Performance of the EndPAC risk score for pancreatic cancer in new onset diabetes patients with missing data – a database study in the British population},
  journal = {Pancreatology},
  year = {2025},
  volume = {25},
  number = {8},
  pages = {1434--1441},
  doi = {10.1016/j.pan.2025.09.017}
}
Kostenlos starten →